Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC9B1P5 (solute carrier family 9, subfamily B, member 1 pseudogene 5) is a human pseudogene belonging to the solute carrier (SLC) family, specifically associated with NHA1/cation proton antiporter 1. As a pseudogene, SLC9B1P5 does not encode a functional protein, and thus does not act as an antiporter or transporter. While some pseudogenes generate regulatory noncoding RNAs that may impact parent gene expression, there is no evidence that SLC9B1P5 performs a defined biological or disease-related function. It is not a therapeutic target and is not the subject of drug development[2][5][8][10]. However, general research on pseudogene regulation highlights possible roles in gene expression control through RNA mechanisms, influencing disease by acting as miRNA decoys, competing for regulatory factors, or contributing to genomic diversity[8].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 9 subfamily B member 1 pseudogene (SLC9B1P5).